Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADAM17 | P78536 | 1/20 | 0.44 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.39 |
| ▸ | MMP2 | P08253 | 1/20 | 0.39 |
| ▸ | MMP3 | P08254 | 1/20 | 0.39 |
| ▸ | MMP12 | P39900 | 1/20 | 0.39 |
| ▸ | MMP13 | P45452 | 1/20 | 0.39 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30023704 | 0.90 | CTSB (0.45) | ADAM17ADAMTS4MMP2MMP3MMP12 | |
| SCHEMBL29625501 | 0.85 | ADAM17 (0.46) | ADAM17 | |
| SCHEMBL12378634 | 0.84 | ADAM17 (0.56) | ADAM17ADAMTS4MMP2MMP3MMP12 | |
| SCHEMBL29494606 | 0.82 | ADAMTS5 (0.39) | ADAM17ADAMTS4MMP2MMP3MMP12 | |
| SCHEMBL14196095 | 0.77 | — | — | |
| SCHEMBL31664382 | 0.75 | ADAM17 (0.46) | ADAM17ADAMTS4MMP2MMP3MMP12 | |
| SCHEMBL398571 | 0.75 | — | — | |
| SCHEMBL12416690 | 0.74 | ADAM17 (0.57) | ADAM17ADAMTS4MMP2MMP3MMP12 | |
| SCHEMBL2874514 | 0.74 | PIN1 (0.54) | — | |
| SCHEMBL25728515 | 0.73 | PIN1 (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4573535-B1 | METHOD FOR PLACING AN EMERGENCY CALL | AUDI AG (DE) | 2026-03-11 | — | — | EP | disclosed |
| EP-4573535-A1 | METHOD FOR PLACING AN EMERGENCY CALL | AUDI AG (DE) | 2025-06-25 | — | — | EP | disclosed |
| CN-119731716-A | Method for making an emergency call | 奥迪股份公司 | 2025-03-28 | — | — | CN | disclosed |
| US-20240350655-A1 | THIOL-CONJUGATION WITH UNSATURATED PHOSPHORUS(V) COMPOUNDS | FORSCHUNGSVERBUND BERLIN E.V. (DE) | 2024-10-24 | — | — | US | disclosed |
| CN-115243719-B | CTB006 and Ponatinib combined application | 北京先通生物医药技术有限公司 | 2024-09-13 | — | — | CN | disclosed |
| EP-4326335-A1 | THIOL-CONJUGATION WITH UNSATURATED PHOSPHORUS(V) COMPOUNDS | Forschungsverbund Berlin E.V. (DE) | 2024-02-28 | — | — | EP | disclosed |
| WO-2024037864-A1 | METHOD FOR PLACING AN EMERGENCY CALL | AUDI AG (DE) | 2024-02-22 | — | — | WO | disclosed |
| CN-117545511-A | Thiol coupling with unsaturated phosphorus (V) compounds | 柏林合作研究学会 | 2024-02-09 | — | — | CN | disclosed |
| US-20230112450-A1 | COMBINED USE OF CTB006 AND PONATINIB | BEIJING SINOTAU BIO-PHARMACEUTICALS TECHNOLOGY CO., LTD. (CN) | 2023-04-13 | — | — | US | disclosed |
| WO-2022223783-A9 | THIOL-CONJUGATION WITH UNSATURATED PHOSPHORUS(V) COMPOUNDS | FORSCHUNGSVERBUND BERLIN E.V. (DE) | 2023-03-02 | — | — | WO | disclosed |
| EP-4115902-A1 | COMBINED USE OF CTB006 AND PONATINIB | Beijing Sinotau Bio-Pharmaceuticals Technology Co., Ltd. (CN) | 2023-01-11 | — | — | EP | disclosed |
| WO-2022223783-A1 | THIOL-CONJUGATION WITH UNSATURATED PHOSPHORUS(V) COMPOUNDS | FORSCHUNGSVERBUND BERLIN E.V. (DE) | 2022-10-27 | — | — | WO | disclosed |
| CN-115243719-A | CTB006 and Ponatinib combined application | 北京先通生物医药技术有限公司 | 2022-10-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240350655-A1 | THIOL-CONJUGATION WITH UNSATURATED PHOSPHORUS(V) COMPOUNDS | PTMS, PHOSPHO1, TYMP | ADAM17 3617/4885ADAMTS4 2209/4885MMP2 3529/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.